Table 1.
The most important clinical characteristics of patients with CR/MDR-PA infection or colonization
| All (n = 92) | Infection (n = 68) | Colonization (n = 24) | OR (95% CI) | |
|---|---|---|---|---|
| Demographic characteristics | ||||
| Male sex (%) | 56 (61) | 44 (65) | 12 (52) | 1.8 (0.7–4.7) |
| Age: median; years (IQR) | 68 (52–74) | 69 (51–74) | 66 (52–75) | |
| Patients ≥65 years (%) | 52 (57) | 37 (54) | 15 (63) | 0.7 (0.3–1.9) |
| Previous contact with health care system | ||||
| Hospitalization within 90 days (%) | 35 (38) | 25 (37) | 10 (42) | 0.8 (0.3–2.1) |
| Long-term healthcare facilities stay within 90 days (%) | 5 (5) | 4 (6) | 1 (4) | 1.4 (0.2–13.5) |
| Antibiotic therapy in previous 90 days (%) | 82 (89) | 60 (88) | 22 (92) | 0.7 (0.1–3.5) |
| Surgery in previous 30 days (%) | 53 (58) | 38 (56) | 15 (63) | 0.8 (0.3–2.0) |
| Intensive care unit stay; duration in days: median (IQR) | 57 (62); 15 (8–24.5) | 40 (59) | 17 (71) | 0.6 (0.2–1.6) |
| Invasive procedures in previous 30 days | ||||
| Bronchoscopy | 30 (33) | 25 (37) | 5 (21) | 2.2 (0.7–6.7) |
| Hemodialysis | 17 (19) | 13 (19) | 4 (17) | 1.2 (0.3–4.1) |
| Endoscopy | 17 (18) | 14 (21) | 3 (13) | 1.8 (0.5–7.0) |
| Other | 16 (17) | 10 (15) | 6 (25) | 0.5 (0.2–1.6) |
| Invasive device use on the microorganism isolation day | ||||
| Mechanical ventilation of the lungs | 47 (51) | 34 (50) | 13 (54) | 0.8 (0.3–2.2) |
| Central venous catheter | 48 (52) | 33 (49) | 15 (63) | 0.6 (0.2–1.5) |
| Urinary catheter | 51 (55) | 38 (56) | 13 (54) | 1.1 (0.4–2.7) |
| Epicystostomy | 9 (10) | 7 (10) | 2 (8) | 1.3 (0.2–6.5) |
| Co-morbidities | ||||
| Congestive cardiac insufficiency | 29 (32) | 21 (31) | 8 (33) | 0.9 (0.3–2.4) |
| Chronic renal failure | 21 (23) | 16 (24) | 5 (21) | 1.2 (0.4–3.6) |
| Diabetes mellitus | 20 (22) | 15 (22) | 5 (21) | 1.1 (0.3–3.4) |
| Chronic pulmonary disease | 17 (18) | 12 (18) | 5 (21) | 0.8 (0.3–2.6) |
| Malignant tumor | 16 (16) | 9 (13) | 7 (25) | 0.4 (0.1–1.1) |
| Hemiplegia | 14 (16) | 11 (16) | 3 (13) | 1.4 (0.3–5.3) |
| Myocardial infarct | 13 (14) | 9 (13) | 4 (17) | 0.8 (0.2–2.8) |
| Cerebrovascular disease | 12 (13) | 11 (16) | 1 (4) | 4.4 (0.5–36.4) |
| Othera | 34 (37) | 27 (40) | 7 (29) | 1.6 (0.6–4.4) |
aHIV, AIDS, hematologic malignancy, dementia, connective tissue disease, liver disease, peripheral vascular disease, ulcer disease, neutropenia, trauma, burn